These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 9351807)

  • 1. The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution: multiple copy flexibility and receptor binding.
    Muller YA; Christinger HW; Keyt BA; de Vos AM
    Structure; 1997 Oct; 5(10):1325-38. PubMed ID: 9351807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of vascular endothelial growth factor determinants for binding KDR and FLT-1 receptors. Generation of receptor-selective VEGF variants by site-directed mutagenesis.
    Keyt BA; Nguyen HV; Berleau LT; Duarte CM; Park J; Chen H; Ferrara N
    J Biol Chem; 1996 Mar; 271(10):5638-46. PubMed ID: 8621427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
    Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
    J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computer modelling of the receptor-binding domains of VEGF and PIGF.
    Walsh TP; Grant GH
    Protein Eng; 1997 Apr; 10(4):389-98. PubMed ID: 9194163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of the complex between VEGF and a receptor-blocking peptide.
    Wiesmann C; Christinger HW; Cochran AG; Cunningham BC; Fairbrother WJ; Keenan CJ; Meng G; de Vos AM
    Biochemistry; 1998 Dec; 37(51):17765-72. PubMed ID: 9922142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor: crystal structure and functional mapping of the kinase domain receptor binding site.
    Muller YA; Li B; Christinger HW; Wells JA; Cunningham BC; de Vos AM
    Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7192-7. PubMed ID: 9207067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure at 1.7 A resolution of VEGF in complex with domain 2 of the Flt-1 receptor.
    Wiesmann C; Fuh G; Christinger HW; Eigenbrot C; Wells JA; de Vos AM
    Cell; 1997 Nov; 91(5):695-704. PubMed ID: 9393862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the VEGF binding site on the Flt-1 receptor.
    Herley MT; Yu Y; Whitney RG; Sato JD
    Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
    Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
    Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solution structure of the VEGF-binding domain of Flt-1: comparison of its free and bound states.
    Starovasnik MA; Christinger HW; Wiesmann C; Champe MA; de Vos AM; Skelton NJ
    J Mol Biol; 1999 Oct; 293(3):531-44. PubMed ID: 10543948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
    Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
    Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The crystal structure of human placenta growth factor-1 (PlGF-1), an angiogenic protein, at 2.0 A resolution.
    Iyer S; Leonidas DD; Swaminathan GJ; Maglione D; Battisti M; Tucci M; Persico MG; Acharya KR
    J Biol Chem; 2001 Apr; 276(15):12153-61. PubMed ID: 11069911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the residues in the extracellular region of KDR important for interaction with vascular endothelial growth factor and neutralizing anti-KDR antibodies.
    Lu D; Kussie P; Pytowski B; Persaud K; Bohlen P; Witte L; Zhu Z
    J Biol Chem; 2000 May; 275(19):14321-30. PubMed ID: 10799512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirements for binding and signaling of the kinase domain receptor for vascular endothelial growth factor.
    Fuh G; Li B; Crowley C; Cunningham B; Wells JA
    J Biol Chem; 1998 May; 273(18):11197-204. PubMed ID: 9556609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.
    Barleon B; Totzke F; Herzog C; Blanke S; Kremmer E; Siemeister G; Marmé D; Martiny-Baron G
    J Biol Chem; 1997 Apr; 272(16):10382-8. PubMed ID: 9099677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells.
    Siemeister G; Schirner M; Reusch P; Barleon B; Marmé D; Martiny-Baron G
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4625-9. PubMed ID: 9539788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.
    Kiba A; Yabana N; Shibuya M
    J Biol Chem; 2003 Apr; 278(15):13453-61. PubMed ID: 12551914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.
    Seetharam L; Gotoh N; Maru Y; Neufeld G; Yamaguchi S; Shibuya M
    Oncogene; 1995 Jan; 10(1):135-47. PubMed ID: 7824266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H, 13C, and 15N backbone assignment and secondary structure of the receptor-binding domain of vascular endothelial growth factor.
    Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
    Protein Sci; 1997 Oct; 6(10):2250-60. PubMed ID: 9336848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.